The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy
Zeyu Wang(Anhui University), Quan Cheng(Central South University), Yuyao Mo(Central South University), Yuze Liu(Central South University), Hao Zhang(Northwestern Polytechnical University), Zhixiong Liu(Central South University), Hui Cao(Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine), Weijie Ye(Central South University), Xun Zhang(Southern University of Science and Technology), Ziyu Dai(Central South University)
Cited by 33
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482